A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT-Reference-Cited by-同舟云学术

A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT

Published:2021-09-01 Issue:9 Volume:20 Page:1123-1146
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Martinón-Torres Federico¹²^ORCID,Bertrand-Gerentes Isabelle³,Oster Philipp³

Affiliation:

1. Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario and Universidad De Santiago De Compostela (USC), Galicia, Spain

2. Genetics, Vaccines, and Pediatric Infectious Diseases Research Group (GENVIP), Instituto De Investigación Sanitaria De Santiago and Universidad De Santiago De Compostela (USC), Galicia, Spain

3. Global Medical Affairs, Sanofi Pasteur, Lyon, France

Funder

Sanofi Pasteur SA, Lyon, France

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1964962

Reference128 articles.

1. Neisseria meningitidis: Biology, Microbiology, and Epidemiology

2. Meningococcal disease: Clinical presentation and sequelae

3. Current Epidemiology and Trends in Meningococcal Disease—United States, 1996–2015

4. World Health Organization (WHO). Meningococcal meningitis - Fact sheet Geneva, Switzerland: World Health Organization (WHO); 2018 [updated Jan 2018; cited 2021 Feb 23]. Available from: http://www.who.int/mediacentre/factsheets/fs141/en/

5. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study;Infectious Diseases and Therapy;2024-07-02

2. Invasive meningococcal disease in older adults: current perspectives and call for action;European Geriatric Medicine;2024-05-06

3. Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT): A review of the evidence and expert opinion;Expert Review of Vaccines;2023-05-15

4. The propositive study: Immunogenicity and safety of a four‐component recombinant protein‐based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living with HIV;HIV Medicine;2023-04-23

5. Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age;Human Vaccines & Immunotherapeutics;2022-08-10